The cell cryopreservation market has seen considerable growth due to a variety of factors.
• The cell cryopreservation market has seen exponential growth in recent years. It will grow from $12.65 billion in 2024 to $15.72 billion in 2025, reflecting a compound annual growth rate (CAGR) of 24.3%.
This growth is driven by the rising demand for cell-based therapies, increased biomedical research, the growing need for organ transplantation, more R&D activities for cell-based therapies, and the increased use of cryopreserved cells.
The cell cryopreservation market is expected to maintain its strong growth trajectory in upcoming years.
• The cell cryopreservation market is expected to grow to $37.01 billion by 2029 with a CAGR of 23.9%.
This is driven by increased demand for IVF procedures, advancements in organ transplantation, biobanking, rising chronic diseases, and government funding. Trends include advancements in cryopreservation techniques, mRNA vaccine storage, cryoprotectants and freezing methods, personalized medicine, and stem cell research.
The increasing number of organ transplantation procedures is anticipated to drive the growth of the cell cryopreservation market. Organ transplants are becoming more frequent due to organ failure from chronic diseases, infections, and injuries. Cryopreservation helps preserve the viability of cells from organs, improving transplant success and reducing immune rejection. For instance, in January 2024, the Health Resources and Services Administration reported 46,632 organ transplants in 2023, marking an 8.7% increase from 2022. The growing number of transplants will propel the cell cryopreservation market.
The cell cryopreservation market covered in this report is segmented –
1) By Product: Cell Freezing Media, Equipment, Consumables
2) By Application: Hepatocytes, Stem Cells, Oocytes And Embryotic cells, Sperm Cells, Other Applications
3) By End-Use Channel: Biopharmaceutical And Pharmaceutical Companies, Research Institutes, Biobanks, In Vitro Fertilization (IVF) Clinics, Other End-Use Channels
Subsegments:
1) By Cell Freezing Media: Serum-Based Freezing Media, Serum-Free Freezing Media
2) By Cryoprotectants: Cryoprotectants
3) By Equipment: Cryopreservation Freezers, Cryo Storage Tanks, Controlled-Rate Freezers
4) By Consumables: Cryovials, Cryo Storage Bags, Cryo Tubes
Companies in the cell cryopreservation market are working on improving cryopreservation medium solutions to better serve customers. Cryopreservation media are specialized formulations that preserve cells or tissues at ultra-low temperatures for long-term storage while maintaining their viability. For example, in April 2024, Pluristyx Inc., a US-based company, introduced PluriFreeze, a cryopreservation medium aimed at enhancing stem cell therapy development by improving the efficiency and quality of induced pluripotent stem cells (iPSCs).
Major companies operating in the cell cryopreservation market are:
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Corning Inc.
• STEMCELL Technologies
• Cryoport Inc.
• BioLife Solutions Inc.
• Nkarta Inc.
• Tn-Sanso Corporation
• Coya Therapeutics
• FUJIFILM Irvine Scientific
• Artiva Biotherapeutics
• Acorn Biolabs Inc.
• ThermoGenesis Holdings Inc.
• Evia Bio Inc.
• Wideblue Limited
• Akron Biotech
• Captivate Bio LLC
• Pluristyx Inc.
• CryoCrate LLC
• PanTHERA CryoSolutions
• ParaTechs Corporation
• Plus Therapeutics
• X-Therma Inc.
• Protein Technologies Limited
North America was the largest region in the cell cryopreservation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.